2025 Fast Facts: 🔷154,270 will be diagnosed 🔷 19,330 patients < 50 y/o We created a video using @Vidyard discussing the benefit of #colorectalcancer #cancerprevention. embed.vidyard.com/share/n8et… #ColorectalCancerAwarenessMonth @FightCRC @OncoAlert @VUMC_Cancer @VUMCDiscoveries

🚨 #HERIZON-GEA-01 Updates & Sequencing HER2-Directed Therapies #GastricCancer 🎙️ Dr.KU & @SteveMaronMD 🗣️: ✅ Zani tislelizumab chemo improves PFS/OS ❗️Retest HER2 at progression #gism #OncTwitter #MedTwitter #ASCO26 @MSKCancerCenter 🔗 Full 🎥👇 oncupdates.com/video-podcast…

🧬 #ScienceSaturday ❓ Why does immunotherapy work so well for some cancers, but often fail in #glioblastoma, one of the most aggressive brain cancers? ➡️ A new study in @NatureCancer suggests the answer may depend less on how many DNA mutations a tumor has, and more on the tumor’s “cell state,” or what the cancer cells are actively doing. ➡️ Researchers studied 181 glioblastoma samples from patients treated with immune checkpoint blockade, a type of immunotherapy designed to help T cells recognize and attack cancer. ➡️ They found that glioblastomas in a mesenchymal, or MES, state were linked to better survival after immunotherapy. These tumors appeared more “immune-visible,” with higher levels of HLA class I, a signal that helps T cells recognize abnormal cells, and more T cell infiltration. ➡️ Surprisingly, #tumor mutational burden, a marker often used to predict immunotherapy response in other cancers, did not predict better outcomes in this glioblastoma group. ➡️ The study also revealed a possible escape route: after #immunotherapy, some tumors shifted away from the MES state toward non-MES states, which may make them less recognizable to the immune system and more resistant to treatment. 🧠 Why this matters: Glioblastoma has been extremely difficult to treat, and checkpoint immunotherapy has mostly been disappointing in this disease. This study suggests that future trials may need to look at a tumor’s RNA “activity pattern,” not just its #DNA mutations, to identify patients who may be more likely to benefit. ✨ Big takeaway: In glioblastoma, the tumor’s current “state of mind” may help predict whether immunotherapy can see it, attack it, and make a difference. Read more here: nature.com/articles/s43018-0… @Nature @DanaFarber @Harvard @harvardmed @MassGenBrigham @broadinstitute @IBMResearch @DanaFarberNews @EAChiocca @JackYGhannam

The House Appropriations Committee passed its version of the FY27 spending bill, including an increase of $110 million compared to the current year’s budget for @theNCI 👏🏽👏🏽 From @TheCancerLetter cancerletter.com/capitol-hil… The Senate will now take up its version of appropriations.

In HER2-positive gastroesophageal adenocarcinoma, progression-free survival was longer with zanidatamab plus chemotherapy, both with and without tislelizumab, than with trastuzumab plus chemotherapy. Full phase 3 HERIZON-GEA-01 trial results and Research Summary: nej.md/4o31eKv

Wonderful interview with Dr @EileenMOReilly Hope given in a difficult diagnosis. Kindness embodied. @MSK_DeptOfMed

I wouldn’t be where I am today without the love and support that @MichelleObama has poured into me over the years. Her story — from her South Side roots to the White House and beyond — is a central part of the Obama Presidential Center.

HI @fireflyann! Sorry, try this one: redcap.link/uqx3kubn for the @VUMCDiscoveries #cancer #wellness #symposium scheduled for tomorrow! TY for your support! #cancercare #patientcare

Id like to share. . Is there a website or only error code?

Looks like exactly the sessions patients want to see! @FightCRC @thequeenvee

#asco26 Colorectal cancer

10 years ago at this very time to the hour I was back sitting in my oncologist office as he was telling me the results from my CT an PET scans and biopsy results. I knew what he was going to say to to actually hear the words your cancer is back after only 51 days since I had

Happening THIS Saturday 6/13/2026! In person or virtually - @VUMChealth @VUMCDiscoveries #Cancer #Survivor #wellness symposium! We would LOVE to have you join! #thriver #patientcare #cancercare #integrativemedicine #psychoncology #livingyourbestlife #sexualdysfunction

Exited to present a few cases at the upcoming @binaytara Miami GI Oncology Conference! Really looking forward to the discussions! Hope to see you there! #OncTwitter #gism #GIOnc #Oncology #MedTwitter #MedX #Binaytara #MedEd

Today is national cancer survivors day. A day to celebrate being here which I never thought possible almost 11 years ago when I was diagnosed, it's a day to remember the ones who aren't here, it's a day to thank everyone that's helped me survive an it's a day to look ahead

Looking forward to being back in Upstate NY and connecting with colleagues! Excellent program put together by @OncBrothers #oncologyupdates

Vanderbilt Hematology/Oncology fellowship class of 2026🎉 I’m so grateful for this amazing group of co-fellows, inspirational mentors (@CathyEngMD and Dr. Bob Coffey), and supportive spouses. While I’m staying for an extra research year, I can’t wait to see what’s next! 🧬🔬💊

Learning a lot this morning from @SylvesterCancer faculty at our annual retreat led by @DrSDNimer

Heartwarming to spend time today with my Dad Ralph … it’s his 96th birthday today … he doesn’t really know who I am anymore, but wow has he been a wonderful father for the past 61 years. He’s also a proud Air Force vet.

Hi, my name is Dr. Brandon Godinich. I’m here to help you fight cancer. ☢️

A very impressive study for how we could prevent lung cancer more than 5 years before it is diagnosed. Using machine learning, discovery of a 14-plasma protein signature of risk that predicts responsiveness to an antibody therapy to interleukin, IL-1β Validated across 8 cohorts @CellCellPress @CharlesSwanton cell.com/cell/fulltext/S0092…